itropropane meets the criteria for classification as carcinogenic (category 1B) in accordance with Regulation (EC) No 1272/2008 and is therefore a carcinogen within the meaning of Directive 2004/37/EC.
Sásaíonn 2-nitreaprópán na critéir lena chur in aicme charcanaigineach (catagóir 1B) i gcomhréir le Rialachán (CE) Uimh. 1272/2008 agus, dá bhrí sin, is carcanaigin é de réir bhrí Threoir 2004/37/CE.